Stocks
Intellia Therapeutics (NTLA) EV/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -4.28 | -19.1 | -28.2 | -3.45 | -3.77 | -4.02 | ||
| Changes by years, y/y, % | +42% | +346% | +48% | -88% | +9% | +4.6% | |||
Intellia Therapeutics. EV/EBITDA
Intellia Therapeutics. EV/EBITDA, changes, %
Intellia Therapeutics (NTLA) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EV/EBITDA | ? | -4.04 | -3.84 | -3.82 | -3.08 | -2.88 | -4.02 | |
| Changes by years, y/y, % | -52% | 0% | -30% | -48% | -29% | |||
| Changes by quarters, q/q, % | -32% | -5% | -1% | -19% | -7% | |||
